Jonathan Hale Zippin
Director/Board Member at FOXWAYNE ENTERPRISES ACQUISITION CORP.
Profile
Jonathan Hale Zippin is the founder of CEP Biotech, Inc. He is currently an Independent Director at FoxWayne Enterprises Acquisition Corp.
and an Associate Professor at Weill Cornell Medical College.
He is also a Member of the Society for Investigative Dermatology and the American Contact Dermatitis Society.
Jonathan Hale Zippin active positions
Companies | Position | Start |
---|---|---|
FOXWAYNE ENTERPRISES ACQUISITION CORP. | Director/Board Member | - |
Weill Cornell Medical College | Corporate Officer/Principal | 2009-12-31 |
Society for Investigative Dermatology | Corporate Officer/Principal | - |
American Contact Dermatitis Society
American Contact Dermatitis Society Medical/Nursing ServicesHealth Services The American Contact Dermatitis Society promotes, supports, develops, and stimulates information about contact dermatitis and occupational skin disease. The private company is based in Bunnell, FL. | Corporate Officer/Principal | - |
Former positions of Jonathan Hale Zippin
Companies | Position | End |
---|---|---|
CEP Biotech, Inc. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Society for Investigative Dermatology | |
American Contact Dermatitis Society
American Contact Dermatitis Society Medical/Nursing ServicesHealth Services The American Contact Dermatitis Society promotes, supports, develops, and stimulates information about contact dermatitis and occupational skin disease. The private company is based in Bunnell, FL. | Health Services |
CEP Biotech, Inc. | |
FoxWayne Enterprises Acquisition Corp.
FoxWayne Enterprises Acquisition Corp. Financial ConglomeratesFinance FoxWayne Enterprises Acquisition Corp. operates as a blank check company. It seeks to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination. It focuses its search for business in the biotechnology and telemedicine sector of the healthcare industry. The company was founded by Robbie Knie on September 17, 2020 and is headquartered in New York, NY. | Finance |
- Stock Market
- Insiders
- Jonathan Hale Zippin